Direct photocatalytic conversion of methane to formaldehyde is highly efficient, avoiding energy‐intensive methanol oxidation. However, its selectivity and activity are severely limited by uncontrollable over‐oxidation: Formaldehyde has lower C‐H dissociation energy than methane, prone to deep overoxidation to CO 2 . Herein, we report H/WO 2.72 hydrogenated nonstoichiometric tungsten oxide photocatalyst. At ambient temperature, it attains 100% HCHO selectivity over all detectable carbonaceous products at 30.94 µmol·h −1 , with 11‐fold higher activity than commercial WO 3 and outperforming most conventional photocatalysts. Operando spectroscopic studies and density functional theory (DFT) calculations reveal that surface W‐H bonds act as a kinetically gated “Anti‐Overoxidation valve,” W–H bonds are preferentially cleaved by reactive oxygen species (·OOH), as they are thermodynamically weaker than the C–H bonds in HCHO and its over‐oxidation intermediate (*HCOOH). Then the generated hydrogen radicals (H*) drive a reverse reduction pathway to convert the *HCOOH back to *HCHO, interrupting deep oxidation. Concurrently, hydrogenation optimizes the electronic structure of WO 2.72 , lowering the HCHO desorption barrier to facilitate timely product release. This work provides a dynamic strategy for complete selectivity in catalytic CH 4 conversion, emphasizing the value of precise kinetic pathway modulation for methane valorization.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: